Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Mol Cancer Res. 2012 Jan 9;10(3):469–482. doi: 10.1158/1541-7786.MCR-11-0177

FIGURE 3.

FIGURE 3

WNT7A knockdown inhibits tumor progression. (a) In vivo xenograft tumor progression. Nude mice were injected i.p. with control cells or WNT7A knockdown cells (#11 or #12). The images provide a direct view of the area in abdominopelvic cavity around the reproductive tract, and intestinal mesentery. (b) Histological examination of intestine following i.p. injection with control and WNT7A knockdown cells. Scale bar = 100μm. (c) Numbers of implanted tumors and total tumor weight 5 weeks after i.p. injection are shown. Data are presented as average number of implants and weight ± SEM. Individual tumors > 2 mm were included. * or ** vs control, P<0.01. (d) Differences in body weight are shown during 5 weeks. * vs control, P<0.05.